Larson Financial Group’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-131
Closed -$1.18K 3462
2025
Q1
$1.18K Buy
+131
New +$1.18K ﹤0.01% 2320